DEA Plays Whack-A-Mole With Unpronounceable Designer Drug
Published Date: 12/11/2025
Rule
Summary
The DEA is extending the temporary ban on MDMB-4en-PINACA, a powerful synthetic drug, keeping it in the strictest control category (Schedule I) for another year until December 12, 2026, or until a permanent decision is made. This means anyone making, selling, or using this drug faces serious legal consequences. The extension helps keep communities safe while the government finishes its review.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 3 costs, 0 mixed.
Schedule I Status Extended One Year
The DEA extended the temporary Schedule I listing for MDMB-4en-PINACA effective December 12, 2025 through December 12, 2026, or until a permanent decision is made. That means anyone who makes, sells, imports, exports, or possesses this drug continues to face the regulatory controls and civil and criminal penalties that apply to Schedule I substances.
Research and Teaching Still Restricted
Researchers, educators, and laboratories that engage in research, instructional activities, or chemical analysis involving MDMB-4en-PINACA remain subject to Schedule I controls and to the same administrative, civil, and criminal sanctions. Those activities remain restricted under this temporary order for the one-year extension.
Salts and Isomers Also Controlled
The temporary extension explicitly covers MDMB-4en-PINACA as well as its salts, isomers, and salts of isomers whenever such variants exist. That means chemical variants of MDMB-4en-PINACA are treated the same as the named compound under Schedule I during the extension period.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06523 — Designation of P2P Methyl Glycidic Acid as a List I Chemical
Starting May 4, 2026, anyone handling P2P methyl glycidic acid—a key chemical used to make illegal drugs like methamphetamine—must follow new government rules and register with the DEA. This means all transactions, big or small, will be closely watched to stop illegal drug production. Businesses dealing with this chemical should act fast to stay legal and avoid penalties.
2026-06521 — Importer of Controlled Substances Application: Lipomed/LGC Standards
Lipomed/LGC Standards wants to become an official importer of certain controlled substances, like 3-Fluoro-N-methylcathinone. This means companies involved with these drugs can comment or ask for a hearing by May 4, 2026. If approved, it could impact how these substances enter the U.S., but no direct costs are mentioned yet.
2026-06051 — Importer of Controlled Substances Application: Usona Institute
Usona Institute wants to become an official importer of some powerful controlled substances like mescaline and psilocybin. People who make or use these drugs can share their thoughts or ask for a hearing by April 29, 2026. This move could impact research and medical use, with no direct cost changes announced yet.
2026-05912 — Bulk Manufacturer of Controlled Substances Application: SpecGx LLC
SpecGx LLC wants to become a big-time maker of some powerful and tightly controlled drugs, including things like psilocybin and fentanyl. People and companies already registered can share their thoughts or ask for a hearing by May 26, 2026. This move could shake up how these substances are made and handled, so keep an eye on the deadlines if you’re involved!
2026-05618 — Schedules of Controlled Substances: Placement of 3-Methoxyphencyclidine (1-(1-(3-Methoxyphenyl)cyclohexyl)piperidine) in Schedule I
Starting April 22, 2026, the DEA is putting 3-methoxyphencyclidine (3-MeO-PCP) into Schedule I, meaning it’s now officially a highly controlled substance with strict rules. This affects anyone who makes, sells, studies, or even possesses 3-MeO-PCP, who will face serious legal consequences. This move helps the U.S. follow international drug laws and keeps communities safer.
2026-05486 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) just updated which chemical mixes are officially exempt from strict drug rules between September 2024 and December 2025. Companies and labs using these chemicals should check the new list to see if their products are approved or denied. You’ve got until May 19, 2026, to share your thoughts, and no extra fees are involved—just a quick review and comment if you want!
Previous / Next Documents
Previous: 2025-22518 — Safety Zone; Patapsco River, Baltimore, MD
On December 13, 2025, from 9:30 to 10:30 p.m., the Coast Guard is setting up a temporary safety zone around a barge in Baltimore’s Patapsco River for a fireworks show. Boats and people can’t enter this 300-foot zone unless the Coast Guard says it’s okay. This keeps everyone safe from fireworks hazards without causing any fees or long delays.
Next: 2025-22545 — Magnuson-Stevens Act Provisions; Fisheries of the Northeastern United States; Fisheries of the Northeastern United States; 2025-2027 Atlantic Herring Fishery Specifications
Starting December 11, 2025, Atlantic herring fishers in the Northeast get a big boost with catch limits rising up to 237% for 2026 and 2027! These changes help protect herring populations while letting fishermen catch more, based on fresh science. This means a healthier ocean and better fishing opportunities for the next three years.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in